Last updated 2026-06-18
- Acquired by Undisclosed Investor(s), Mar 2022
Total raised
—
Stage
Acquired
Founded
1999
Headcount
19
HQ
Kiryat Ata, Israel
Sector
Health Tech & Life Sciences
About
Novetide manufactures commercially available peptide products, with a robust pipeline of products in development. The companys technology platform is based on several proprietary technologies and expertise in the development and production of peptides through sequence assembly, downstream processing, characterization, and documentation of peptide drug substances. Novetides two FDA-approved production sites have flexible and scalable manufacturing capabilities, with output ranging from grams to tons. Its peptides are currently sold to multinational pharmaceutical companies, start-up companies, and researchers worldwide. Teva Pharmaceuticals has held 50% of Novetide since 2000.
Q&A
- What is Novetide's primary business?
- Novetide specializes in peptide development and manufacture, producing commercially available peptide products and maintaining a pipeline of products in development.
- When was Novetide founded?
- Novetide was founded in January 1999.
- How many employees does Novetide have?
- Novetide has an employee count in the 11-50 range.
- What is Novetide's primary sector?
- Novetide's primary sector is Health Tech & Life Sciences.
- Does Novetide have FDA-approved production sites?
- Yes, Novetide operates two FDA-approved production sites with flexible and scalable manufacturing capabilities.
- Who are Novetide's target customers?
- Novetide's target customers include multinational pharmaceutical companies, start-up companies, and researchers worldwide.
- What is Teva Pharmaceuticals' relationship with Novetide?
- Teva Pharmaceuticals has held 50% ownership of Novetide since 2000.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
biopharmaceuticalbiotechnologymanufacturingpharma-companiespeptidespharmaceuticals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/1228122 |
Identifiers & details
| Founded | 1999-1 |
|---|---|
| Employees (exact) | 19 |
| Status reason | Acquired (Inactive) by Undisclosed Investor(s) on Mar 2022 - ceased to operate |
Acquisitions & public offerings
Acquired by Undisclosed Investor(s) 2022-03
Radar intelligence
Patents
| EPO | 11 |
|---|